Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics

References

• Egorova N, Cumming T, Shirbin C, Veldsman M, Werden E, Brodtmann A. Lower cognitive control network connectivity in stroke participants with depressive features. Transl Psychiatry. 2018;7(11):4. doi:10.1038/s41398-017-0038-x29520018
   PubMed Web of Science ®Google Scholar
• Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: a scientific statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2017;48(2):e30–e43. doi:10.1161/STR.000000000000011327932603
   PubMed Web of Science ®Google Scholar
• Tang WK, Chan SS, Chiu HF, et al. Poststroke depression in Chinese patients: frequency, psychosocial, and radiological determinants. J Geriatr Psychiatry Neurol. 2005;18:45–51. doi:10.1177/089198870427176415681628
   PubMed Web of Science ®Google Scholar
• Fang J, Yan W, Jiang G, et al. Serotonin transporter gene polymorphism in Chinese patients with poststroke depression: a case-control study. Stroke. 2011;42(5):1461–1463. doi:10.1161/STROKEAHA.110.59867221441157
   PubMed Web of Science ®Google Scholar
• Bartoli F, Lillia N, Lax A, et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat. 2013;2013:862978.23533964
   PubMedGoogle Scholar
• Sugawara N, Metoki N, Hagii J, et al. Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan. Neuropsychiatr Dis Treat. 2015;11:2551–2556. doi:10.2147/NDT.S9130326491334
   PubMed Web of Science ®Google Scholar
• Zhang WN, Pan YH, Wang XY, Zhao Y. A prospective study of the incidence and correlated factors of post-stroke depression in China. PLoS One. 2013;8(11):e78981.24260141
   PubMed Web of Science ®Google Scholar
• Mikami K, Jorge RE, Adams HP Jr, et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry. 2011;19:1007–1015. doi:10.1097/JGP.0b013e31821181b021358384
   PubMed Web of Science ®Google Scholar
• Chemerinski E, Robinson RG, Arndt S, et al. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis. 2001;189:421–425.11504318
   PubMed Web of Science ®Google Scholar
• Pan JX, Xia JJ, Deng FL, et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry. 2018;8(1):130. doi:10.1038/s41398-018-0183-x29991685
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhu Z, Zhao J, et al. Malondialdehyde: a novel predictive biomarker for post-stroke depression. J Affect Disord. 2017;220:95–101. doi:10.1016/j.jad.2017.05.02328600933
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Z, Sun D, et al. The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res. 2010;32(4):340–346. doi:10.1179/016164110X1265639366508020482998
   PubMed Web of Science ®Google Scholar
• Sellgren CM, Gracias J, Jungholm O, et al. Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls. Transl Psychiatry. 2019;9(1):37. doi:10.1038/s41398-019-0378-930696814
   PubMed Web of Science ®Google Scholar
• Chen JJ, Bai SJ, Li WW, et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl Psychiatry. 2018;8(1):192. doi:10.1038/s41398-018-0245-030232320
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Li WW, et al. Age-specific urinary metabolite signatures and functions in patients with major depressive disorder. Aging (Albany NY). 2019;11(17):6626–6637. doi:10.18632/aging.10213331493765
   PubMedGoogle Scholar
• Xie J, Chen C, Hou LJ, Zhou CJ, Fang L, Chen JJ. Dual metabolomic platforms identified a novel urinary metabolite signature for Hepatitis B virus-infected patients with depression. Diabetes Metab Syndr Obes. 2020;13:1677–1683.32547129
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Zeng L, Zhou CJ, Zheng P, Xie P. Urinary metabolite signature in bipolar disorder patients during depressive episode. Aging (Albany NY). 2019;11(3):1008–1018. doi:10.18632/aging.10180530721880
   PubMedGoogle Scholar
• Zhang W, Zhang XA. A novel urinary metabolite signature for non-invasive post-stroke depression diagnosis. Cell Biochem Biophys. 2015;72(3):661–667. doi:10.1007/s12013-014-0472-927352185
   PubMed Web of Science ®Google Scholar
• Liang ZH, Jia YB, Li ZR, et al. Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2019;12:1379–1386.31496775
   PubMed Web of Science ®Google Scholar
• Meader N, Moe-Byrne T, Llewellyn A, Mitchell AJ. Screening for post-stroke major depression: a meta-analysis of diagnostic validity studies. J Neurol Neurosurg Psychiatry. 2014;85:198–206. doi:10.1136/jnnp-2012-30419423385849
   PubMed Web of Science ®Google Scholar
• Chen L, Eaton WW, Gallo JJ, Nestadt G. Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. J Affect Disord. 2000;59(1):1–11. doi:10.1016/S0165-0327(99)00132-910814765
   PubMed Web of Science ®Google Scholar
• Zheng P, Chen JJ, Huang T, et al. A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res. 2013;12(12):5904–5911. doi:10.1021/pr400939q24224655
   PubMed Web of Science ®Google Scholar
• Zheng S, Yu M, Lu X, et al. Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta. 2010;411(3–4):204–209. doi:10.1016/j.cca.2009.11.00319913000
   PubMed Web of Science ®Google Scholar
• Yao JK, Dougherty GG Jr, Reddy RD, et al. Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One. 2010;5(3):e9508. doi:10.1371/journal.pone.000950820209081
   PubMed Web of Science ®Google Scholar
• Jones DA. Rosacea, reactive oxygen species, and azelaic Acid. J Clin Aesthet Dermatol. 2009;2(1):26–30.
   Google Scholar
• Lukić I, Getselter D, Ziv O, et al. Antidepressants affect gut microbiota and Ruminococcusflavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry. 2019;9(1):133. doi:10.1038/s41398-019-0466-x30967529
   PubMed Web of Science ®Google Scholar
• Schmidtner AK, Slattery DA, Gläsner J, et al. Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner. Transl Psychiatry. 2019;9(1):223. doi:10.1038/s41398-019-0556-931519869
   PubMed Web of Science ®Google Scholar
• Chen JJ, He S, Fang L, et al. Age-specific differential changes on gut microbiota composition in patients with major depressive disorder. Aging (Albany NY). 2020;12(3):2764–2776. doi:10.18632/aging.10277532040443
   PubMedGoogle Scholar
• Tan BYQ, Paliwal PR, Sharma VK. Gut microbiota and stroke. Ann Indian Acad Neurol. 2020;23(2):155–158. doi:10.4103/aian.AIAN_483_1932189854
   PubMed Web of Science ®Google Scholar
• Chen R, Wu P, Cai Z, et al. PuerariaeLobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biochem. 2019;65:101–114.30710886
   PubMed Web of Science ®Google Scholar
• Chen JJ, Xie J, Zeng BH, et al. Absence of gut microbiota affects lipid metabolism in the prefrontal cortex of mice. Neurol Res. 2019;41(12):1104–1112. doi:10.1080/01616412.2019.167502131587617
   PubMed Web of Science ®Google Scholar